AI-Driven Predictive Biomarker Discovery with Contrastive Learning to Improve Clinical Trial Outcomes

Gustavo Arango-Argoty, Damian E. Bikiel, Gerald J. Sun, Elly Kipkogei, Kaitlin M. Smith, Sebastian Carrasco Pro, Etai Jacob
doi: https://doi.org/10.1101/2024.01.31.24302104

Article Information

doi 
https://doi.org/10.1101/2024.01.31.24302104
History 
  • August 7, 2024.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Gustavo Arango-Argoty1,*,
  2. Damian E. Bikiel1,
  3. Gerald J. Sun1,
  4. Elly Kipkogei1,
  5. Kaitlin M. Smith1,
  6. Sebastian Carrasco Pro2 and
  7. Etai Jacob1,*
  1. 1Oncology Data Science, Oncology R&D, AstraZeneca, Waltham, MA, USA
  2. 2Life Sciences, Tempus AI, Boston, MA, USA
  1. ↵*Corresponding authors: gustavo.arango{at}astrazeneca.com, etai.jacob{at}astrazeneca.com
Back to top
Posted August 07, 2024.
Download PDF

Supplementary Material

Data/Code
Email
AI-Driven Predictive Biomarker Discovery with Contrastive Learning to Improve Clinical Trial Outcomes
Gustavo Arango-Argoty, Damian E. Bikiel, Gerald J. Sun, Elly Kipkogei, Kaitlin M. Smith, Sebastian Carrasco Pro, Etai Jacob
medRxiv 2024.01.31.24302104; doi: https://doi.org/10.1101/2024.01.31.24302104
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area